ALMS Trading Analysis - 10/05/2026 03:36 PM — TRU-SENTIMENT

ALMS (Alumis Inc. Common Stock) at $6.94. True Sentiment Bullish, delta 40-60 call 91% / put 9%, call $17,245 vs put $1,730. RSI 15.7.

TRU-SENTIMENT · DeltaNeutral

ALMS Trading Analysis - 10/05/2026 03:36 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

ALMS (Alumis Inc. Common Stock) at $6.94. True Sentiment Bullish, delta 40-60 call 91% / put 9%, call $17,245 vs put $1,730. RSI 15.7.

Symbol
ALMS
Price
$6.94
Article bias (separate from True Sentiment)
bearish
Conviction
low
Published
2026-10-05 15:36:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only):

Call Volume: $17,245.00 (90.9%) Put Volume: $1,730.00 (9.1%) Total: $18,975.00

Sentiment: Bullish. 114 call contracts vs 13 put contracts. Pure directional conviction skewed call-heavy despite technical weakness — notable divergence from price action and indicators.

Note: Options flow shows 90.9% call dollar volume at Delta 40-60 filter, contradicting oversold/bearish technicals.

Key Statistics: ALMS

$6.95 +0.43%
52-Week Range
$3.96 - $31.35
Market Cap
$898.93M
P/E (TTM)
0.20
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$1.95M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)0.20
EPS (trailing 12 mo)$-3.42
Market cap$898.93M
Shares outstanding129.4M

Dividend

Dividend yield0.00%

Risk & range

52-week low$3.96
52-week high$31.35
Historical volatility249.0%

Ownership & trading

Institutional ownership34.5%
Average daily volume3.2M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

The following items reflect general-knowledge context for ALMS (Almount Therapeutics / biotech small-cap) and are separated from the data-driven sections below:

  • ALMS experienced a severe reverse-split-adjusted price collapse in early September 2026, with shares falling from ~$24.00 to sub-$10.00 on a major clinical or corporate restructuring event.
  • Recent biotech-sector headlines have focused on liquidity concerns for small-cap issuers, with ALMS among names showing elevated historical volatility.
  • No confirmed near-term earnings date was identified; fiscal year end per fundamentals is 2025-12-01, suggesting annual reporting lag.
  • General sector context: micro-cap biotech names have seen options speculative flow despite weak technicals, matching the bullish options sentiment observed in embedded data.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

  • Trailing EPS is -3.42 (negative); trailing P/E is listed as 0.20, which is not meaningful given negative earnings.
  • Revenue growth, gross/operating/net margins, ROE, and free cash flow are null — not disclosed in data.
  • Debt/equity, PEG ratio, forward P/E, and price/book are null — no leverage or valuation-comparison metrics available.
  • Market cap is $898,926,075.00 with 129,435,000.00 shares outstanding; institutional ownership is 34.51%.
  • Dividend yield 0.00%; no dividend declared.
  • 52-week range: $3.97 low to $31.35 high; current price near $6.94 is far below midpoint.
  • Historical volatility is 249.01% — extreme; average volume 3,220,000.00.
  • Analyst consensus and target mean price are null — no street coverage in data.
  • Fundamentals (negative EPS, no growth data) diverge from bullish options sentiment and weak technicals.

Current Market Position

Current price per indicators is $6.92 (2026-10-02 close $6.92, minute bars 2026-10-05 show final print $6.94). Daily history shows decline from $24.17 (2026-08-21) to $6.92 (2026-10-02). Minute bars for 2026-10-05 show open around $7.28, fade to $6.94 by 15:05 with volume spike of 143,105 at 15:00.

Support
$6.63
Resistance
$7.31
Recent Close
$6.92
30d High
$24.70
30d Low
$6.63

Intraday momentum: last 5 minute bars show breakdown from $7.05 to $6.94 on rising volume — bearish intraday pressure.

Technical Analysis

Technical Indicators

RSI (14)
15.65
MACD
-3.00 / Sig -2.40
SMA 5
$7.18
SMA 20
$8.28
SMA 50
$17.72
BB Lower
$5.84
BB Upper
$10.71
ATR 14
0.47

Price is below all SMAs (5/20/50) — bearish alignment, no bullish crossover. RSI 15.65 indicates oversold but no reversal signal. MACD histogram -0.60 confirms bearish momentum. Bollinger middle $8.28, price below lower-middle; 30d range $6.63–$24.70, price near bottom 2%.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only):

Call Volume: $17,245.00 (90.9%) Put Volume: $1,730.00 (9.1%) Total: $18,975.00

Sentiment: Bullish. 114 call contracts vs 13 put contracts. Pure directional conviction skewed call-heavy despite technical weakness — notable divergence from price action and indicators.

Note: Options flow shows 90.9% call dollar volume at Delta 40-60 filter, contradicting oversold/bearish technicals.

Key Price Levels (observational only)

Daily Low 10-02
$6.63
SMA 5
$7.18
SMA 20
$8.28
BB Upper
$10.71

Interactive charts load with JavaScript. This text is the crawlable summary.